La Jolla Pharmaceutical (LJPC) Short Interest Ratio & Short Volume → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free LJPC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis La Jolla Pharmaceutical Short Interest DataCurrent Short Volume95,700 sharesPrevious Short Volume202,500 sharesChange Vs. Previous Month-52.74%Dollar Volume Sold Short$594,297.00Short Interest Ratio / Days to Cover0.5Last Record DateJuly 31, 2022Outstanding Shares24,937,000 sharesFloat Size25,070,000 sharesShort Percent of Float0.38%Today's Trading Volume66,708 sharesAverage Trading Volume158,476 sharesToday's Volume Vs. Average42% Short Selling La Jolla Pharmaceutical ? Sign up to receive the latest short interest report for La Jolla Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLJPC Short Interest Over TimeLJPC Days to Cover Over TimeLJPC Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. La Jolla Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202295,700 shares $594,297.00 -52.7%0.4%0.5 $6.21 7/15/2022202,500 shares $1.25 million -62.7%0.8%1 $6.18 6/30/2022543,500 shares $1.73 million -2.0%2.2%3.3 $3.19 6/15/2022554,800 shares $1.78 million -1.6%2.2%9.3 $3.20 5/31/2022564,000 shares $2.26 million -2.4%2.2%9.2 $4.01 5/15/2022577,700 shares $2.32 million +5.0%2.3%8.9 $4.01 Get the Latest News and Ratings for LJPC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for La Jolla Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 4/30/2022550,000 shares $2.24 million +0.2%2.2%8.2 $4.08 4/15/2022548,700 shares $2.40 million +4.0%2.1%7.8 $4.37 3/31/2022527,700 shares $2.25 million -6.1%2.1%6.9 $4.27 3/15/2022561,800 shares $2.22 million -4.2%2.2%6.6 $3.96 2/28/2022586,300 shares $2.40 million -3.7%2.2%5.7 $4.09 2/15/2022608,900 shares $2.72 million -4.5%2.3%5 $4.46 1/31/2022637,300 shares $2.95 million -1.9%2.4%4.9 $4.63 1/15/2022649,400 shares $3.20 million -4.7%2.4%5.1 $4.92 12/31/2021681,300 shares $3.17 million +59.9%2.5%5.5 $4.65 12/15/2021426,200 shares $1.79 million +47.1%1.6%3.4 $4.21 11/30/2021289,800 shares $1.13 million +3.3%1.1%2.5 $3.90 11/15/2021280,600 shares $1.13 million -6.3%1.0%2.9 $4.01 10/29/2021299,400 shares $1.20 million -17.4%1.1%3.3 $4.02 10/15/2021362,500 shares $1.44 million -73.9%1.3%3.4 $3.96 9/30/20211,390,000 shares $5.55 million -2.1%5.1%12.5 $3.99 9/15/20211,420,000 shares $5.67 million +2.2%5.2%8.3 $3.99 8/31/20211,390,000 shares $5.85 million -11.5%5.1%7.5 $4.21 8/13/20211,570,000 shares $6.25 million -6.6%5.8%6.4 $3.98 7/30/20211,680,000 shares $6.06 million -2.9%6.2%6.4 $3.61 7/15/20211,730,000 shares $6.50 million -3.9%6.4%6.7 $3.76 6/30/20211,800,000 shares $7.70 million -23.1%6.7%6.6 $4.28 6/15/20212,340,000 shares $11.47 million -4.1%8.7%10 $4.90 5/28/20212,440,000 shares $10.49 million +4.3%9.0%10 $4.30 5/14/20212,340,000 shares $8.19 million -7.5%8.7%10.5 $3.50 4/30/20212,530,000 shares $10.95 million -17.3%9.4%9.9 $4.33 4/15/20213,060,000 shares $12.55 million +2.0%11.3%9.4 $4.10 3/31/20213,000,000 shares $12.66 million +0.3%11.1%3.1 $4.22 3/15/20212,990,000 shares $17.01 million +16.3%11.1%3.1 $5.69 2/26/20212,570,000 shares $15.06 million +7.1%9.5%2.7 $5.86 2/12/20212,400,000 shares $16.49 million -9.8%8.9%2.6 $6.87 1/29/20212,660,000 shares $17.13 million -15.3%9.9%2.8 $6.44 1/15/20213,140,000 shares $17.79 million +10.2%11.6%3.5 $5.67 12/31/20202,850,000 shares $11.34 million -2.7%10.6%3.6 $3.98 12/15/20202,930,000 shares $13.04 million +5.4%10.9%12.3 $4.45The #1 lithium battery stock to have on your radar in 2024! (Ad)Discover Why Zacks Small Cap Research Issued a “STRONG BUY” Rating on this Little-Known NASDAQ-traded Green Energy Company!Learn More Here LJPC Short Interest - Frequently Asked Questions What is La Jolla Pharmaceutical's current short interest? Short interest is the volume of La Jolla Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 95,700 shares of LJPC short. 0.38% of La Jolla Pharmaceutical's shares are currently sold short. Learn More on La Jolla Pharmaceutical's current short interest. What is a good short interest percentage for La Jolla Pharmaceutical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.38% of La Jolla Pharmaceutical's floating shares are currently sold short. Is La Jolla Pharmaceutical's short interest increasing or decreasing? La Jolla Pharmaceutical saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 95,700 shares, a decline of 52.7% from the previous total of 202,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is La Jolla Pharmaceutical's float size? La Jolla Pharmaceutical currently has issued a total of 24,937,000 shares. Some of La Jolla Pharmaceutical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. La Jolla Pharmaceutical currently has a public float of 25,070,000 shares. How does La Jolla Pharmaceutical's short interest compare to its competitors? 0.38% of La Jolla Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to La Jolla Pharmaceutical: Compugen Ltd. (2.25%), Cellectis S.A. (1.21%), Scilex Holding (7.13%), Kodiak Sciences Inc. (3.76%), Molecular Partners AG (0.16%), Elevation Oncology, Inc. (13.03%), Cardiol Therapeutics Inc. (0.42%), Genfit S.A. (0.19%), DBV Technologies S.A. (0.27%), Vaxart, Inc. (10.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short La Jolla Pharmaceutical stock? Short selling LJPC is an investing strategy that aims to generate trading profit from La Jolla Pharmaceutical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against La Jolla Pharmaceutical? A short squeeze for La Jolla Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LJPC, which in turn drives the price of the stock up even further. How often is La Jolla Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LJPC, twice per month. The most recent reporting period available is July, 31 2022. More Short Interest Resources from MarketBeat Related Companies: Compugen Short Interest Cellectis Short Interest Scilex Short Interest Kodiak Sciences Short Interest Molecular Partners Short Interest Elevation Oncology Short Interest Cardiol Therapeutics Short Interest Genfit Short Interest DBV Technologies Short Interest Vaxart Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LJPC) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldIs Tesla going out of business?DTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold